# Why Biogen?
Keywords: Biogen, biosimilars, neurological diseases, autoimmune diseases, rare diseases, manufacturing, scientific excellence, distribution, environmental impact

> Biogen is a global biotechnology company focused on developing therapies for serious neurological, autoimmune, and rare diseases, as well as advancing biosimilars to improve healthcare affordability and sustainability.

## Details
- [Our History](#): Founded in 1978, Biogen is one of the first global biotechnology companies, aiming to help patients worldwide through innovative therapies and cost-saving biosimilars.
- [Our Processes](#): Biogen is dedicated to improving patient lives by ensuring the quality and reliability of its medicines through rigorous manufacturing operations.
- [Scientific Excellence](#): With 40 years of expertise in biologics, Biogen has the capability to produce and supply advanced biosimilars reliably.
- [Distribution Capability](#): Biogen has an exemplary track record in delivering biosimilars, ensuring no patient dose is ever missed through transparent stakeholder collaboration and supply chain investments.
- [Environmentally Conscious](#): Biogen minimizes environmental impact by employing advanced engineering systems in state-of-the-art manufacturing facilities to reduce waste and optimize resource use.